| Starting this week, we'll be sending the Coronavirus Update three times a week instead of every day, with a more in-depth report on Fridays. Keep an eye out for our next dispatch on Friday.
The FDA is expected to tighten vaccine guidelines, a vaccine from Johnson & Johnson enters Phase III trials, and Covid patients and researchers turn to support groups. Here's what you should know: Headlines FDA expected to tighten vaccine approval guidelines to assuage Americans' concerns The FDA is expected to release new guidelines for emergency use authorization of a coronavirus vaccine as soon as this week. A recent survey found that 50 percent of Americans said they would get the vaccine today, compared to 72 percent in May. This move by the FDA is intended to assuage concerns about the safety and efficacy of a rapidly approved vaccine. The new guidelines will also make it difficult for a vaccine to be approved before Election Day. Johnson & Johnson vaccine begins largest Phase III trials yet in the US Johnson & Johnson's coronavirus vaccine entered Phase III trials on Monday. It will be the largest of its kind in the US, with plans to enroll 60,000 participants. Unlike its competitors, this vaccine doesn't need to be stored at subzero temperatures and may only require one dose. If it works, this could make it easier to inoculate large numbers of people very quickly. Online Covid-19 groups offer support for people with the virus and scientists studying it Over the last six months, hundreds of thousands of people who have tested positive for coronavirus have congregated in Reddit threads, Facebook groups, and other online spaces where they post about their experiences with the disease and offer support. While there are still trolls and misinformation, these groups have largely been a positive space for people seeking solace and advice. They've also been a vital source of data for medical researchers. Daily Distraction For WIRED, writer Tom Comitta took a look at the last lines from 137 science fiction and fantasy books. Then, he turned them into a story of their own. Something to Read Four years after its launch, Pokémon Go is still a rare salve online. Players—of whom there are as many as 150 million worldwide—are sociable, outdoorsy, and amused in their hunt for virtual monsters. It's a stark contrast to another alternate-reality game of sorts—QAnon. Sanity Check Facial recognition tech is just about everywhere these days. But there are still a few ways to ensure a moment of anonymity. One Question How might a Covid-19 vaccine be biased? Leading vaccine candidates, notably those from Russia and China, use an engineered version of a virus that causes common colds to help recipients develop immunity to Covid-19. But if people have already gotten this milder virus, preexisting antibodies might make the vaccine less effective. It's far more likely that this will be the case if you live in the developing world—meaning that these vaccines will work best for residents of the richest countries in the world. Covid-19 Care Package ❓ From social distancing to viral spread to staying sane, here's everything we know and advise about the coronavirus. 📦 The Covid-19 virus can linger on objects for as little as a few hours or as long as a couple of days, depending on the surface. Here's the research. 😷 If you're planning to go out in public anytime soon, you're going to need a mask. Here are the best ones you can buy, or how to make one at home. 🧼 It's not just your hands that need washing—your gadgets, clothes, and home need it too. Here's how to properly disinfect your stuff. 💻 Some of you are work-from-home pros, but if you're new to it, here's how to stay productive without losing your mind. 😔 It's hard not to be anxious about a global pandemic, but here's how you can protect yourself and your family without spiraling, and how to not hate the loved ones you're quarantined with. ✂️ It may still be a while before you can see your hairstylist, so here's how to cut your hair at home, plus other ways to keep yourself lookin' fresh. 🦠 Read all of our coronavirus coverage here. | 
0 Comments:
Post a Comment